#pharmaceutical AI
52 related articles
Puzzles Cut Alzheimer's Risk by 25% in…
·2 min
Puzzles Cut Alzheimer's Risk by 25% in Men — But Why Don't They Work for Women?
A study found cognitive training (mind games) reduces Alzheimer's risk by ~25% in men but not women. We analyze cognitive reserve theory, gender differences, and implications for personalized digital health.
Read more →
Will AI Really Replace Human Jobs? Sig…
·3 min
Will AI Really Replace Human Jobs? Signing Authority, Jevons Paradox, and the Distribution Dilemma
Will AI replace human jobs? This article examines AI employment anxiety through accountability, Jevons Paradox, and value distribution — who really benefits from the productivity boom?
Read more →
The Complete Guide to Breaking Into Da…
·3 min
The Complete Guide to Breaking Into Data Science: Career Paths, Learning Resources, and Job Search Strategies
A complete guide to breaking into data science: learning resources, degree vs. online courses, building a portfolio, and career prospects. Ideal for career changers and upskilling professionals.
Read more →
·3 min
Vivo's India Joint Venture: A New Blueprint for Chinese Smartphone Brands Going Local
Vivo's India JV signals a new era for Chinese smartphone brands. We analyze the strategic logic, geopolitical context, and what it means for OPPO, Xiaomi, and India's manufacturing ambitions.
Read more →
·4 min
The Boundaries of AI Safety Guardrails: Deep Reflections Sparked by a Single Prompt
A Reddit post sparks debate: what happens when a user asks AI to "push guardrails to the limit"? An in-depth look at AI safety guardrails, jailbreaks, and content balance.
Read more →
·5 min
Is AI Inference Really Profitable? Deconstructing the Cost Economics of Inference vs. Training
Are AI companies really losing money? This article deconstructs the fundamental differences between training and inference costs, revealing why pure AI inference services have structural profitability.
Read more →
Should Frontier AI Models Like GPT-5.6…
·4 min
Should Frontier AI Models Like GPT-5.6 Be Open-Sourced? A Deep Dive into the Open vs. Closed Debate
Should frontier AI models be open-sourced? This deep dive explores the key debates around democratization, misuse risks, commercial sustainability, and governance — and the middle paths between open and closed.
Read more →
·3 min
Python Beginner's Guide from Scratch: Why Python Is Your Best Choice
A complete Python beginner's guide covering language features, six ideal learner profiles, and seven application areas. Discover why Python is the best choice for coding beginners and AI learners.
Read more →
·3 min
Why Frontier AI Models Need Mandatory Third-Party Safety Testing
Exploring why frontier AI models need mandatory third-party safety testing across cybersecurity, biosecurity, and autonomy risks, and the paradigm shift from voluntary commitments to mandatory oversight.
Read more →
·2 min
LifeSciBench: A Life Science AI Benchmark Built by 173 Scientists
LifeSciBench is a life science AI benchmark developed by 173 biotech and pharma scientists, featuring 750 expert tasks across seven research workflows.
Read more →
·3 min
What Happens to Developer Jobs When AI Writes 80% of the Code? A Deep Dive into Anthropic's Landmark Report
Anthropic's latest report reveals over 80% of its codebase is AI-written and engineer output has grown 8x. A deep analysis of AI's impact on software development, the taste moat, AI bubble stages, and loop engineering.
Read more →
·2 min
Self-Driving Labs: In AI Materials Science, the Moat Is the Lab, Not the Model
Self-driving labs integrate AI decision-making with automated experiments for closed-loop materials R&D acceleration. Learn why the real moat in AI materials science is the lab, not the model.
Read more →
·3 min
Anthropic Releases AI Safety Policy Proposal to Advance U.S. Leadership in Frontier Safety
Anthropic CEO Dario Amodei releases AI safety policy proposals aimed at establishing U.S. leadership in frontier AI safety, with implications for global AI governance.
Read more →
·2 min
Claude Opus 4.7 Conquers NMR Spectroscopy Analysis: A General-Purpose AI Rivaling Specialized Chemistry Software
Anthropic's latest research shows Claude Opus 4.7 matches or surpasses dedicated NMR spectroscopy software. Explore the technical significance, drug discovery implications, and future of AI science tools.
Read more →
·2 min
GPT-Rosalind: A Detailed Look at OpenAI's AI Model Built for Life Sciences
OpenAI launches GPT-Rosalind, an enterprise AI model for life sciences. Integrating GPT-5.5 agentic coding and tool use, it covers drug discovery, molecular design, data analysis, and experimental workflows.
Read more →
·4 min
PAO Project in Practice: Bayesian Optimization-Driven Aspen Plus Automated Simulation Tutorial
Learn how the PAO project integrates Bayesian optimization with Aspen Plus via YAML configuration for automated multi-objective chemical process optimization.
Read more →
·4 min
AI Super Week: Hundred-Billion-Dollar Capital, the Agent Revolution, Safety Crises, and China's New Landscape
Deep analysis of AI Super Week's four themes: Alphabet's $80B raise and Anthropic's IPO ignite capital markets, OpenAI Codex drives the Agent work revolution, Florida's first AI lawsuit sounds safety alarms, and China's WeChat Agent charts a differentiated path.
Read more →
·3 min
AI Is Now Building AI: Is Anthropic's Warning Genuine Concern or Business Strategy?
Anthropic warns AI can now self-optimize and build next-gen AI, with 80% code contribution and 52x human optimization. Released amid $65B funding and IPO filing — genuine concern or strategic move?
Read more →
·2 min
Hands-On with Google's AI Research Tools: Expanding from Biological to Social Sciences
A social science researcher shares hands-on experience with Google's latest AI research tools, analyzing Google's leadership in AI-accelerated science and future multi-disciplinary expansion.
Read more →
Tech Frontiers·3 min
OpenAI Leadership Shakeup as Greg Brockman Returns, Cerebras IPO Hits $67B Valuation, Open-Source Agents Dominate GitHub
OpenAI co-founder Greg Brockman takes over product strategy, Cerebras IPO hits $67B market cap, and open-source agents OpenHuman and OpenClack dominate GitHub as AI shifts from capability to deployment.
Read more →